A strategy for addressing aspirin hypersensitivity in patients requiring urgent PCI

Patrick Schiano1, Philippe Gabriel Steg, Franck Barbou

  • 1Hôpital d'Instruction des Armées du Val de Grâce, Paris, France.

Insights

For acute myocardial infarction patients allergic to aspirin, a strategy combining percutaneous coronary intervention with glycoprotein IIb/IIIa blockers and rapid oral desensitization offers a viable treatment path. This approach manages hypersensitivity while ensuring critical antiplatelet therapy.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Aspirin is crucial for acute myocardial infarction (AMI) management, especially with stent implantation.
  • Optimal treatment for aspirin-hypersensitive patients with ST-elevation AMI remains undefined.

Purpose of the Study:

  • To propose and outline a management strategy for aspirin-hypersensitive patients undergoing percutaneous coronary intervention for ST-elevation AMI.

Main Methods:

  • Percutaneous coronary intervention (PCI) with intravenous glycoprotein IIb/IIIa receptor blockers for antiplatelet therapy.
  • Rapid oral desensitization initiated in the hours following PCI, once the patient is clinically stable.

Main Results:

  • This strategy aims to provide effective antiplatelet coverage despite aspirin hypersensitivity.
  • Facilitates necessary intervention in a high-risk patient population.

Conclusions:

  • A combined approach of PCI, glycoprotein IIb/IIIa blockers, and rapid oral desensitization is a suggested management strategy for aspirin-hypersensitive patients with ST-elevation AMI.
  • This strategy addresses the challenge of treating these patients, enabling essential interventions and therapy.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...